Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

NCT00317161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Hepatitis B
Haemophilus Influenzae Type b
Whole Cell Pertussis
Tetanus

Interventions

BIOLOGICAL: DTPw-HBV/Hib-MenAC conjugate vaccine

Sponsor

GlaxoSmithKline